BRPI1006778A2 - procedimento de síntese de um composto de sais de cloreto de benzazolo(3,2-a) quinolínio amino substituído - Google Patents
procedimento de síntese de um composto de sais de cloreto de benzazolo(3,2-a) quinolínio amino substituídoInfo
- Publication number
- BRPI1006778A2 BRPI1006778A2 BRPI1006778A BRPI1006778A BRPI1006778A2 BR PI1006778 A2 BRPI1006778 A2 BR PI1006778A2 BR PI1006778 A BRPI1006778 A BR PI1006778A BR PI1006778 A BRPI1006778 A BR PI1006778A BR PI1006778 A2 BRPI1006778 A2 BR PI1006778A2
- Authority
- BR
- Brazil
- Prior art keywords
- salt compound
- chloride salt
- synthesis procedure
- substituted
- benzazole
- Prior art date
Links
- -1 amino substituted benzazole Chemical class 0.000 title 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/416,174 US8124770B2 (en) | 2009-04-01 | 2009-04-01 | Fluorescent cellular markers |
| PCT/US2010/036437 WO2010135751A2 (en) | 2009-04-01 | 2010-05-27 | Fluorescent cellular markers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1006778A2 true BRPI1006778A2 (pt) | 2018-02-06 |
Family
ID=42826743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1006778A BRPI1006778A2 (pt) | 2009-04-01 | 2010-05-27 | procedimento de síntese de um composto de sais de cloreto de benzazolo(3,2-a) quinolínio amino substituído |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8124770B2 (pt) |
| EP (2) | EP3091014A1 (pt) |
| JP (1) | JP2013527122A (pt) |
| CN (1) | CN102762555B (pt) |
| BR (1) | BRPI1006778A2 (pt) |
| WO (1) | WO2010135751A2 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9085574B2 (en) * | 2009-04-01 | 2015-07-21 | Beatriz Zayas | Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition |
| US9758518B2 (en) | 2015-03-04 | 2017-09-12 | Pimera, Inc. | Compositions, uses and methods for making them |
| TR201809990T4 (en) | 2014-05-09 | 2018-08-27 | Pimera Inc | NEW COMPOSITIONS, USES AND METHODS FOR THEIR MAKING. |
| WO2016004513A1 (en) * | 2014-07-11 | 2016-01-14 | Simon Fraser University | Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods |
| WO2016044636A2 (en) * | 2014-09-17 | 2016-03-24 | Sistema Universitario Ana G. Mendez, Inc. | Method for producing benzazoloquinolium (bqs) salts and using the biological activity of the composition |
| US20240066023A1 (en) * | 2014-09-17 | 2024-02-29 | Sistema Universitario Ana G. Mendez, Inc. | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition |
| EP3601286A4 (en) | 2017-03-28 | 2020-09-23 | Pimera, Inc. | NEW CRYSTALLINE FORMS OF A POL1 INHIBITOR |
| CN115232120B (zh) * | 2021-04-23 | 2023-09-05 | 香港理工大学深圳研究院 | pH荧光探针及其合成方法与应用 |
| CN115286646A (zh) * | 2022-08-31 | 2022-11-04 | 郑州大学 | 检测聚氨酯中胺类化合物残留的探针及其制备方法与应用 |
| CN119101915B (zh) * | 2024-08-28 | 2025-10-03 | 桂林理工大学 | 一种利用电化学氧化偶联反应构建苯唑[3,2-a]喹啉盐的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4590275A (en) * | 1982-03-12 | 1986-05-20 | Commonwealth Of Puerto Rico | Benzoheterazolo[3,2-a]quinolinium salts |
-
2009
- 2009-04-01 US US12/416,174 patent/US8124770B2/en active Active
-
2010
- 2010-05-27 WO PCT/US2010/036437 patent/WO2010135751A2/en not_active Ceased
- 2010-05-27 JP JP2012503792A patent/JP2013527122A/ja active Pending
- 2010-05-27 EP EP16172043.8A patent/EP3091014A1/en not_active Withdrawn
- 2010-05-27 EP EP10778536A patent/EP2414355A4/en not_active Withdrawn
- 2010-05-27 BR BRPI1006778A patent/BRPI1006778A2/pt not_active IP Right Cessation
- 2010-05-27 CN CN201080021846.3A patent/CN102762555B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010135751A3 (en) | 2011-11-10 |
| US8124770B2 (en) | 2012-02-28 |
| CN102762555B (zh) | 2015-04-29 |
| EP2414355A2 (en) | 2012-02-08 |
| EP3091014A1 (en) | 2016-11-09 |
| US20100256378A1 (en) | 2010-10-07 |
| EP2414355A4 (en) | 2012-11-21 |
| JP2013527122A (ja) | 2013-06-27 |
| CN102762555A (zh) | 2012-10-31 |
| WO2010135751A2 (en) | 2010-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1006778A2 (pt) | procedimento de síntese de um composto de sais de cloreto de benzazolo(3,2-a) quinolínio amino substituído | |
| NO2024006I1 (no) | Piflufolastat (18F) or a pharmaceutically acceptable salt thereof | |
| FIC20240026I1 (fi) | Etrasimodi tai sen farmaseuttisesti hyväksyttävä suola, kuten etrasimodiarginiini | |
| NO2023047I1 (no) | Cedazuridine, or a pharmaceutically acceptable salt thereof | |
| NO2021039I1 (no) | pibrentasvir or a pharmaceutically acceptable salt thereof - forlenget SPC | |
| NO2022033I1 (no) | Rimegepant or a pharmaceutically acceptable salt thereof | |
| HUS000500I2 (hu) | Upadacitinib vagy gyógyszerészetileg elfogadható sója | |
| BRPI0811280A2 (pt) | Compostos amino-heterocíclicos | |
| EP2192109A4 (en) | Bicyclic -amino acid derivative | |
| IL205071A0 (en) | Azolecarboxamide compound or salt thereof | |
| EP2305641A4 (en) | SULPHONAMIDE COMPOUND OR SALT THEREOF | |
| EP2186799A4 (en) | AROMATIC SULPHONIUM SALT CONNECTION | |
| CL2008000355A1 (es) | Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro. | |
| EP2511269A4 (en) | FUSED HETEROCYCLIC COMPOUND HAVING AN AMINO GROUP | |
| BRPI0907563A2 (pt) | Derivados de 4,5-di-hidro-xazol-2-il amina | |
| BRPI0819568A2 (pt) | métodos para a preparação de um composto | |
| FIC20230001I1 (fi) | Lasmiditaani tai tämän farmaseuttisesti hyväksyttävä suola | |
| IL204516A0 (en) | Organic amine salt of 6-fluoro-3-hydroxy-2- | |
| EP2062902A4 (en) | Lithium salt | |
| BRPI1016258A2 (pt) | sais derivados de n-fosfonometilglicina guanidina | |
| IL196656A0 (en) | Sulfonamide compound or salt thereof | |
| IL198284A0 (en) | Processes for preparing palonosetron salts | |
| IL181485A0 (en) | Processes for preparing novel montelukast salts | |
| BRPI0814800A2 (pt) | Derivados de aminoácidos | |
| GB0715712D0 (en) | Amino acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15I | Others concerning applications: loss of priority | ||
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |